DLL3 Antibody (rovalpituzumab) - Humanized
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-28317
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA, Flow Cytometry, Functional
Label
Unconjugated
Antibody Source
Recombinant Monoclonal Human IgG1 Clone # rovalpituzumab
Concentration
LYOPH mg/ml
Product Specifications
Immunogen
DLL3
Clonality
Monoclonal
Host
Human
Isotype
IgG1
Endotoxin Level
< 0.001EU/ug,determined by LAL method.
Description
Expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
Also known as 'rovalpituzumab'.
Upon receipt, store immediately at -20C or lower for 24 months in a lyophilized state. - 80C for 3 months after reconstitution. Avoid repeated freeze-thaw cycles.
Also known as 'rovalpituzumab'.
Upon receipt, store immediately at -20C or lower for 24 months in a lyophilized state. - 80C for 3 months after reconstitution. Avoid repeated freeze-thaw cycles.
Scientific Data Images for DLL3 Antibody (rovalpituzumab) - Humanized
ELISA: DLL3 Antibody (rovalpituzumab) - Humanized[NBP3-28317] -
Immobilized human DLL3 His at 2 ug/mL can bind DLL3 Antibody (rovalpituzumab) - Humanized, EC50=0.01407 ug/mL.
Flow Cytometry: DLL3 Antibody (rovalpituzumab) - Humanized[NBP3-28317] -
Human DLL3 HEK293 cells were stained with DLL3 Antibody (rovalpituzumab) - Humanized and negative control protein respectively, washed and then followed by PE and analyzed with FACS, EC50=0.01586 ug/mL.Applications for DLL3 Antibody (rovalpituzumab) - Humanized
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Functional
Optimal dilutions of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Reconstitution
Reconstitute with sterile, distilled water to a final concentration of 1 mg/ml. Gently shake to solubilize completely. Do not vortex.
Formulation
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Preservative
No Preservative
Concentration
LYOPH mg/ml
Shipping
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C.
Background: DLL3
Additional DLL3 Products
Product Documents for DLL3 Antibody (rovalpituzumab) - Humanized
Product Specific Notices for DLL3 Antibody (rovalpituzumab) - Humanized
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...